ATP13A3
protein-codingATPase 13A3, the group of ATPase orphan transporters
Gene summary
ATP13A3 is a member of the P-type ATPase family of proteins that transport a variety of cations across membranes. Other P-type ATPases include ATP7B (MIM 606882) and ATP7A (MIM 300011).[supplied by OMIM, Aug 2008]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~95.7 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: SD
Disease ID:MONDO:0015924
Submitter: ClinGen
ATP13A3 encodes an ATPase that plays a role in polyamine transport to a variety of cations across the membrane. This gene has been seen to be related with definitive evidence for pulmonary arterial hypertension by several studies [Gräf et al., 2018; Barozzi et al., 2019; Lerche et al., 2019; Zhu et al., 2019; Wang et al., 2019 and Machado et al., 2021]. The mode of inheritance of ATP13A3 showed a semi-dominant pattern and the majority of the variants detected were missense, although nonsense and frameshift variants have also been detected. Functional assays confirmed that ATP13A3 is expressed in primary pulmonary arterial smooth muscle cells, endothelial cells and blood outgrowth endothelial cells from patients. ATP13A3 knockdown by siRNA in BOECs showed decreased proliferation and BOECs transfected with siRNA of ATP13A3 showed increased apoptosis [Gräf et al., 2018].
Inheritance Pattern: AD
Disease ID:MONDO:0009935
Submitter: PanelApp Australia
Clinical Genomic Database (CGD)
Manifestation: Cardiovascular
Intervention: Cardiovascular
Rationale: Individuals with Pulmonary hypertension, primary, may manifest at variable ages, and awareness may allow surveillance, diagnosis of sequelae, and prompt management (including medical and/or surgical management) of disease
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to ATP13A3 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_001367549.1. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 3 | 45 | 6 | 54 | ||
| missense | 2 | 147 | 14 | 3 | 166 | |
| nonsense | 1 | 1 | 1 | 3 | ||
| start loss | 1 | 1 | ||||
| frameshift | 3 | 1 | 4 | |||
| splice donor/acceptor (+/-2bp) | 1 | 8 | 9 | |||
| Total | 5 | 4 | 160 | 59 | 9 | 237 |
Highest pathogenic variant AF is 0.000013699719
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_001354478.1 | 32 | MANE Select | |
| Ensembl | ENSP00000494937.2 | 32 | MANE Select | |
| RefSeq | NP_001361765.1 | 31 | Standard | |
| RefSeq | NP_001424922.1 | 31 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Biological Process
- cation transport
- cellular calcium ion homeostasis
Molecular Function
- ATP binding
- ATPase activity
- metal ion binding
Cellular Component
- cell
- membrane
- integral component of membrane
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000439040
- Coding exons
- 31
- Length
- 95693
- Individuals with no LoFs
- 124805
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 16
- Defined
- 124821
- p
- 0.0000641
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 3.01 | 444 | 662 | 0.670 | 0.0000339 | 8070 |
| Missense (PolyPhen) | 66 | 191.34 | 0.34494 | 2298 | ||
| Synonymous | -0.136 | 230 | 227 | 1.01 | 0.0000124 | 2312 |
| Loss of Function | 6.59 | 8 | 65.5 | 0.122 | 0.00000305 | 843 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00013 | 0.00013 | rare |
| Latino/Admixed American | 0.00015 | 0.00014 | rare |
| Ashkenazi Jewish | 0.00030 | 0.00030 | rare |
| East Asian | 0 | 0.0 | absent |
| Finnish | 0.000093 | 0.000093 | rare |
| European (Non-Finnish) | 0.000027 | 0.000026 | rare |
| South Asian | 0 | 0.0 | absent |
| Other | 0.00017 | 0.00016 | rare |
dbNSFP Gene Annotations
Source:
Recessive Scores
- pRec
- 0.0969
Intolerance Scores
- LoFtool
- 0.124
- RVIS EVS
- -0.97
- RVIS percentile EVS
- 8.95
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.403
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |